MoneyWorks4Me

Asston Pharmaceuticals informs about certificate

14 Oct 2026 Evaluate
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Asston Pharmaceuticals has informed that it enclosed the certificate for the quarter ended 30th September, 2026, as received from the Registrar and Share Transfer Agent of the Company, Maashitla Securities. 

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1776.40
Dr. Reddys Labs. 1224.25
Cipla 1330.10
Lupin 1980.80
Zydus Lifesciences 1143.40
View more..